Accra: The Ghana Health Service (GHS) has reported an increase in Mpox infections, with 13 new cases bringing the total to 670 as of October 8. The outbreak, which began on May 15, 2025, has resulted in three deaths and is affecting all 16 regions and approximately 100 districts across Ghana.

According to Ghana News Agency, the Ghana Health Service has emphasized its vigilance in monitoring the situation through a robust surveillance system across the regions. Public health measures have been activated by regional health directorates, including contact tracing, to curb further spread of the disease. Collaborative efforts with the Ministry of Health are ongoing to implement necessary interventions to contain the outbreak.

Prof. Samuel Kaba Akoriyea, Director General of GHS, assured the public that existing protocols for detection, management, and control of infectious diseases are being followed rigorously. He encouraged calm and reassured citizens that there is no immediate cause for alarm.

The GHS has advised the public to practice good hygiene, avoid close contact with symptomatic individuals, and use protective gear when caring for the sick. They have also urged citizens to report any suspected cases to health facilities promptly. The government remains committed to safeguarding public health and is confident in its capability to manage and prevent a larger outbreak.

Mpox, a viral disease, is transmitted through close contact with an infected person or contaminated materials. Symptoms include rash, fever, headaches, muscle aches, back pain, low energy, and swollen lymph nodes. The GHS recommends regular handwashing or use of hand sanitizers, wearing masks, and covering lesions until rashes heal to prevent transmission.

The World Health Organization (WHO) declared Mpox a public health emergency of international concern in August last year due to a new variant spreading in Africa. More than 17,000 suspected cases and 517 deaths were reported across the continent, according to the Africa Centre for Disease Control and Prevention. The WHO has approved an Mpox vaccine to enhance access for those at risk, especially in Africa, where recent outbreaks have affected over 20,000 individuals.